Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Percy Ivy

Showing results (11-20 of 232) with videos related to

Pageof 24
Sort By:
JAMA Oncology|January 11, 2019
Drivers of Clinical Trial Participation-Demographics, Disparities, and Eligibility CriteriaGrace Mishkin, Fernanda Arnaldez, S Percy Ivy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Novel designs and end points for phase II clinical trialsAlex A Adjei, Michaele Christian, Percy Ivy
Breast Cancer Research : BCR|June 16, 2011
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transitionNaoko Takebe, Ronald Q Warren, S Percy Ivy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Reply to V. Launay-Vacher, T. Shimokata et al, and C. Porta et alJan H Beumer, Hussein Tawbi, S Percy Ivy
Frontiers in Oncology|March 13, 2019
Radiopharmaceuticals for Relapsed or Refractory LeukemiasCharles A Kunos, Jacek Capala, Susan Percy Ivy
Current Cancer Drug Targets|October 8, 2003
Clinical development of 17-allylamino, 17-demethoxygeldanamycinEdward A Sausville, Joseph E Tomaszewski, Percy Ivy
Frontiers in Oncology|July 19, 2019
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master FilesCharles A Kunos, Jacek Capala, Susan Percy Ivy
Cancer Prevention Research (Philadelphia, Pa.)|September 23, 2010
Molecular conversations and the development of the hair follicle and basal cell carcinomaPamela Jo Harris, Naoko Takebe, S Percy Ivy
Oncology (Williston Park, N.Y.)|January 22, 2016
Challenges and Opportunities for Immunotherapies in Gynecologic CancersJung-min Lee, S Percy Ivy, Elise C Kohn
Trends in Cancer|July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic LethalityS Percy Ivy, Johann de Bono, Elise C Kohn
Pageof 24

Showing results (11-20 of 232) with videos related to

Sort By:
Pageof 24
JAMA Oncology|January 11, 2019
Drivers of Clinical Trial Participation-Demographics, Disparities, and Eligibility CriteriaGrace Mishkin, Fernanda Arnaldez, S Percy Ivy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Novel designs and end points for phase II clinical trialsAlex A Adjei, Michaele Christian, Percy Ivy
Breast Cancer Research : BCR|June 16, 2011
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transitionNaoko Takebe, Ronald Q Warren, S Percy Ivy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Reply to V. Launay-Vacher, T. Shimokata et al, and C. Porta et alJan H Beumer, Hussein Tawbi, S Percy Ivy
Frontiers in Oncology|March 13, 2019
Radiopharmaceuticals for Relapsed or Refractory LeukemiasCharles A Kunos, Jacek Capala, Susan Percy Ivy
Current Cancer Drug Targets|October 8, 2003
Clinical development of 17-allylamino, 17-demethoxygeldanamycinEdward A Sausville, Joseph E Tomaszewski, Percy Ivy
Frontiers in Oncology|July 19, 2019
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master FilesCharles A Kunos, Jacek Capala, Susan Percy Ivy
Cancer Prevention Research (Philadelphia, Pa.)|September 23, 2010
Molecular conversations and the development of the hair follicle and basal cell carcinomaPamela Jo Harris, Naoko Takebe, S Percy Ivy
Oncology (Williston Park, N.Y.)|January 22, 2016
Challenges and Opportunities for Immunotherapies in Gynecologic CancersJung-min Lee, S Percy Ivy, Elise C Kohn
Trends in Cancer|July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic LethalityS Percy Ivy, Johann de Bono, Elise C Kohn
Pageof 24